Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

SAN DIEGO — Dapagliflozin provides significant benefits in the treatment of chronic kidney disease (CKD) even when initiated in patients with the most severe stages of the disease who are ...

including the recently updated Kidney Diseases Improving Global Outcomes (KDIGO) guideline for the management of CKD, a newly published consensus statement on renal genetics by The National Kidney ...

Background: The combined effect of depression and nutritional-inflammatory status on mortality in the chronic kidney disease (CKD) population is unclear. Methods: We prospectively analyzed 3,934 ...

Desidustat is a small molecule inhibitor of hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) discovered and developed by Zydus Lifesciences for the treatment of anemia associated with chronic ...

The recently proposed updates to the draft Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guideline, which were released for public comment in August, underscore the striking ...